Labuxtinib
CAS No. 1426449-01-5
Labuxtinib( —— )
Catalog No. M37250 CAS No. 1426449-01-5
Labutinib is a selective inhibitor of the c-kit tyrosine kinase .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 373 | In Stock |
|
| 5MG | 337 | In Stock |
|
| 10MG | 541 | In Stock |
|
| 25MG | 1074 | In Stock |
|
| 50MG | 1516 | In Stock |
|
| 100MG | 2037 | In Stock |
|
| 200MG | 2744 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLabuxtinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLabutinib is a selective inhibitor of the c-kit tyrosine kinase .
-
DescriptionLabuxtinib is c-kit tyrosine kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR | c-Kit
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1426449-01-5
-
Formula Weight377.37
-
Molecular FormulaC20H16FN5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (331.24 mM; Ultrasonic )
-
SMILESC(NC1=CC(=CC=C1C)C=2N=C(ON2)[C@@H]3[C@@H](F)C3)(=O)C=4N5C(=NC4)C=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yeh Vince, et al. Imidazopyridine compounds and compositions as c-kit kinase inhibitors and their preparation. World Intellectual Property Organization, WO2013033070 A1. 2013-03-07.
molnova catalog
related products
-
ICA-105574
ICA-105574 is an activator of hERG that binds to the channel to remove inactivation, thus increasing peak current amplitude and shortening the action potential. It also modulates activation kinetics of the channel.
-
BLU-945
BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs).
-
WZ4002
WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM.
Cart
sales@molnova.com